![]() |
Code of Federal Regulations (Last Updated: July 5, 2024) |
![]() |
Title 32 - National Defense |
![]() |
Subtitle A - Department of Defense |
![]() |
Chapter V - Department of the Army |
![]() |
SubChapter H - Supplies and Equipment |
![]() |
Part 626 - BIOLOGICAL DEFENSE SAFETY PROGRAM |
![]() |
Subpart C - BDP Contractors |
§ 626.18 - BDP contract requirements.
-
(a) Contractors performing work with BL-3 and BL-4 material must prepare a plan detailing procedures for controlling laboratory mishaps involving etiologic agents.
(1) The contractor shall have the necessary equipment and trained personnel for controlling the mishap.
(2) In the event of an incidental release of a BDP etiologic agent from appropriate laboratory biocontainment that may result in personnel exposure, approved emergency procedures will be initiated immediately to effectively protect personnel and the environment and to constrain the spread of contamination. The affected areas will be decontaminated before normal operations are resumed.
(3) Special medical surveillance will be started as soon as possible for all workers present in the potentially affected area at the time of the mishap.
(4) Local emergency support agencies, such as law enforcement, fire departments, health departments, and governments will be informed of BDP activities and the appropriate support necessary, to include any equipment and training to provide effective emergency response. Agreements with external agencies must be formalized.
(5) The contractor shall be required to review the plan annually and consult external agencies if there is an agreement for them to provide assistance. This should be done in coordination with the contracting agency.
(b) [Reserved]